Primary Physicians Research, Inc   Report issue

For profit Phase 2
Founded: Pittsburgh PA United States (1980)
Status: No NME R&D (1980)

Organization Overview

First Clinical Trial
2006
NCT00332956
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Primary Physicians Research, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

peramivir (rapivab) (1 trial)

rf1v vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Plague (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2